Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 2 August 1963:
Vol. 141. no. 3579, p. 426
DOI: 10.1126/science.141.3579.426
Prev | Table of Contents | Next

Articles

Congenital Malformations in Hamster Embryos after Treatment with Vinblastine and Vincristine

Vergil H. Ferm 1

1 Department of Pathology, Dartmouth Medical School, Hanover, New Hampshire

Intravenous injection of vinblastine or vincristine, two antitumor chemotherapeutic agents used in humans, into pregnant golden hamsters on the 8th day of gestation, causes an increase in the fetal mortality rate and the appearance of a significant number of congenital malformations in the surviving fetuses.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Management of Cancer During Pregnancy.
D. C. Doll, Q. S. Ringenberg, and J. W. Yarbro (1988)
Arch Intern Med 148, 2058-2064
   Abstract »    PDF »
An Analysis of the Hydra Assay's Applicability and Reliability as a Developmental Toxicity Prescreen.
E.M. Johnson, L.M. Newman, B.E.G. Gabel, T.F. Boerner, and L.A. Dansky (1988)
International Journal of Toxicology 7, 111-126
   Abstract »    PDF »
Pattern of Response of Intact Drosophila to Known Teratogens.
R.L. Schuler, M.A. Radike, B.D. Hardin, and R.W. Niemeier (1985)
International Journal of Toxicology 4, 291-303
   Abstract »    PDF »
Pathologic Effects of Purified Polybrominated Biphenyl Congeners in Rats.
B. T. Akoso, S. D. Sleight, S. D. Aust, and H. D. Stowe (1982)
International Journal of Toxicology 1, 1-21
   Abstract »    PDF »
Application of the Hydra Assay for Rapid Detection of Developmental Hazards.
E. M. Johnson and B. E.G. Gabel (1982)
International Journal of Toxicology 1, 57-71
   Abstract »    PDF »
Successful culture of rat embryos on human serum: use in the detection of teratogens.
C. Chatot, N. Klein, J Piatek, and L. Pierro (1980)
Science 207, 1471-1473
   Abstract »    PDF »
Immunosuppressive and Cytotoxic Chemotherapy: Long-Term Complications.
P. S. SCHEIN and S. H. WINOKUR (1975)
Ann Intern Med 82, 84-95
   Abstract »    PDF »
Procarbazine Therapy for Hodgkin's Disease in Early Pregnancy.
J. H. Wells, J. R. Marshall, and P. P. Carbone (1968)
JAMA 205, 935-937
   Abstract »    PDF »
Severe Vinblastine-Induced Leukopenia During Late Pregnancy with Delivery of a Normal Infant.
J. J. NORDLUND, V. T. DEVITA, and P. P. CABBONE (1968)
Ann Intern Med 69, 581-582
   Abstract »    PDF »
A Methylhydrazine Derivative in Hodgkin's Disease and Other Malignant Neoplasms: Therapeutic and Toxic Effects Studied in 51 Patients.
K. W. BRUNNER and C. W. YOUNG (1965)
Ann Intern Med 63, 69-86
   Abstract »    PDF »
Delivery of a Normal Infant During the Course of Oral Vinblastine Sulfate Therapy for Hodgkin's Disease.
J. G. ARMSTRONG, R. W. DYKE, P. J. FOUTS, and C. J. JANSEN (1964)
Ann Intern Med 61, 106-107
   Abstract »    PDF »
Vinblastine Sulfate in Hodgkin's Disease in Pregnancy.
A. I. ROSENZWEIG, Q. E. CREWS JR., and H. G. HOPWOOD (1964)
Ann Intern Med 61, 108-112
   Abstract »    PDF »
Use of Vinblastine Sulfate to Treat Hodgkin's Disease During Pregnancy.
M. J. LACHER (1964)
Ann Intern Med 61, 113-115
   Abstract »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)